tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market

AbbVie (4AB) Ratios

Compare
26 Followers

AbbVie Ratios

DE:4AB's free cash flow for Q4 2025 was $0.84. For the 2025 fiscal year, DE:4AB's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.67 0.67 0.66 0.87 0.96
Quick Ratio
0.56 0.56 0.55 0.76 0.84
Cash Ratio
0.12 0.12 0.14 0.34 0.31
Solvency Ratio
0.17 0.17 0.10 0.11 0.17
Operating Cash Flow Ratio
0.44 0.44 0.49 0.60 0.84
Short-Term Operating Cash Flow Coverage
2.22 2.18 2.76 3.18 5.80
Net Current Asset Value
$ -108.13B$ -108.13B$ -106.22B$ -91.31B$ -93.06B
Leverage Ratios
Debt-to-Assets Ratio
0.51 0.52 0.50 0.45 0.46
Debt-to-Equity Ratio
-21.06 -21.12 20.40 5.80 3.72
Debt-to-Capital Ratio
1.05 1.05 0.95 0.85 0.79
Long-Term Debt-to-Capital Ratio
1.06 1.06 0.95 0.83 0.77
Financial Leverage Ratio
-40.97 -40.97 40.65 13.00 8.04
Debt Service Coverage Ratio
2.28 2.28 1.61 1.68 3.45
Interest Coverage Ratio
5.77 8.08 3.25 5.74 8.12
Debt to Market Cap
0.18 0.17 0.21 0.22 0.22
Interest Debt Per Share
40.28 40.04 39.94 35.26 37.50
Net Debt to EBITDA
2.25 2.26 4.18 2.75 2.27
Profitability Margins
Gross Profit Margin
73.34%83.71%69.99%62.42%70.00%
EBIT Margin
15.42%15.08%11.58%15.60%27.06%
EBITDA Margin
46.26%46.26%26.47%31.61%41.64%
Operating Profit Margin
26.72%34.69%16.22%23.49%31.21%
Pretax Profit Margin
10.79%10.79%6.60%11.51%23.21%
Net Profit Margin
6.91%6.91%7.59%8.95%20.39%
Continuous Operations Profit Margin
6.92%6.92%7.61%8.97%20.40%
Net Income Per EBT
64.06%64.06%115.12%77.81%87.82%
EBT Per EBIT
40.37%31.10%40.67%48.99%74.39%
Return on Assets (ROA)
3.15%3.15%3.17%3.61%8.53%
Return on Equity (ROE)
-361.58%-129.24%128.66%46.94%68.60%
Return on Capital Employed (ROCE)
18.02%23.40%9.48%13.17%16.58%
Return on Invested Capital (ROIC)
10.57%13.69%8.85%9.56%14.02%
Return on Tangible Assets
9.25%9.25%10.66%10.39%30.19%
Earnings Yield
1.08%1.03%1.36%1.77%4.14%
Efficiency Ratios
Receivables Turnover
4.86 4.86 5.16 4.87 5.16
Payables Turnover
0.47 2.77 5.74 5.54 5.94
Inventory Turnover
3.29 2.01 4.04 4.98 4.87
Fixed Asset Turnover
9.61 9.61 10.97 10.89 11.76
Asset Turnover
0.46 0.46 0.42 0.40 0.42
Working Capital Turnover Ratio
-4.88 -4.47 -6.26 -18.37 -13.92
Cash Conversion Cycle
-584.48 124.91 97.43 82.31 84.28
Days of Sales Outstanding
75.13 75.13 70.75 74.96 70.76
Days of Inventory Outstanding
110.81 181.35 90.28 73.29 75.02
Days of Payables Outstanding
770.42 131.57 63.59 65.94 61.50
Operating Cycle
185.94 256.48 161.02 148.24 145.77
Cash Flow Ratios
Operating Cash Flow Per Share
10.69 10.63 10.63 12.92 14.08
Free Cash Flow Per Share
10.50 9.95 10.08 12.48 13.69
CapEx Per Share
0.18 0.68 0.55 0.44 0.39
Free Cash Flow to Operating Cash Flow
0.98 0.94 0.95 0.97 0.97
Dividend Paid and CapEx Coverage Ratio
1.59 1.48 1.57 2.02 2.32
Capital Expenditure Coverage Ratio
57.84 15.68 19.31 29.39 35.89
Operating Cash Flow Coverage Ratio
0.28 0.28 0.28 0.38 0.39
Operating Cash Flow to Sales Ratio
0.31 0.31 0.33 0.42 0.43
Free Cash Flow Yield
4.81%4.35%5.67%8.05%8.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
92.55 96.82 73.48 56.34 24.18
Price-to-Sales (P/S) Ratio
6.35 6.69 5.58 5.04 4.93
Price-to-Book (P/B) Ratio
-119.61 -125.12 94.54 26.45 16.59
Price-to-Free Cash Flow (P/FCF) Ratio
20.77 22.97 17.63 12.42 11.80
Price-to-Operating Cash Flow Ratio
20.55 21.50 16.72 12.00 11.47
Price-to-Earnings Growth (PEG) Ratio
1.18 -116.18 -6.08 -0.96 9.22
Price-to-Fair Value
-119.61 -125.12 94.54 26.45 16.59
Enterprise Value Multiple
15.98 16.72 25.26 18.71 14.11
Enterprise Value
452.08B 472.99B 376.67B 321.29B 341.20B
EV to EBITDA
15.98 16.72 25.26 18.71 14.11
EV to Sales
7.39 7.73 6.69 5.92 5.88
EV to Free Cash Flow
24.17 26.55 21.12 14.56 14.07
EV to Operating Cash Flow
23.76 24.86 20.03 14.07 13.68
Tangible Book Value Per Share
-51.40 -51.10 -51.81 -43.84 -46.48
Shareholders’ Equity Per Share
-1.84 -1.83 1.88 5.86 9.74
Tax and Other Ratios
Effective Tax Rate
0.36 0.36 -0.15 0.22 0.12
Revenue Per Share
34.35 34.15 31.85 30.72 32.78
Net Income Per Share
2.37 2.36 2.42 2.75 6.68
Tax Burden
0.64 0.64 1.15 0.78 0.88
Interest Burden
0.70 0.72 0.57 0.74 0.86
Research & Development to Revenue
0.15 0.15 0.23 0.14 0.11
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.01
Income Quality
4.49 4.50 4.39 4.74 2.11
Currency in USD